NOV 21, 2018 9:00 AM PST

Current Controversies in the Epidemiology, Diagnosis, and Management of Vaginal Infections

Speaker
  • Associate Professor of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham
    Biography
      Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. Her clinical and research interests focus on HIV and sexually transmitted diseases (specifically vaginal infections) among sexual minority women of color and women with increased numbers of recent sexual partners. Dr. Muzny currently has a K23 career development award from the National Institute of Allergy and Infectious Diseases to study the pathogenesis of bacterial vaginosis among African American women who have sex with women. She is currently an Associate Professor in the Division of Infectious Diseases at UAB, a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center, and an Associate Scientist for the UAB Center for AIDS Research.

    Abstract
    DATE: November 21,2018
    TIME:  09:00am PST, 12:00pm EST
     
    Vaginal infections are a source of considerable morbidity among women. It is estimated that there are more than 10 million office visits per year due to vaginal infections. The three main causes of infectious vaginitis are vulvovaginal candidiasis (VVC), trichomoniasis, and bacterial vaginosis (BV). Each one may cause distressing vaginal symptomatology and the latter two may cause upper genital tract complications. These infections may also contribute to the transmission and acquisition of HIV. This webinar reviews current controversies in the epidemiology, diagnosis, and management of vaginal infections, particularly BV and trichomoniasis. It will include a discussion as to whether or not BV is a sexually transmitted infection, the pathogenesis of incident BV and the role of the BV biofilm, and updated BV treatment recommendations. With regards to trichomonas, the webinar will discuss whether or not it should be a reportable disease, new diagnostic methods, and updated treatment recommendations.
     
    At the end of the webinar, learners should be able to:
    • Describe the epidemiology of BV, particularly as it relates to sexual transmission
    • Be knowledgeable on updated treatment options for BV and trichomonas
    • Be knowledgeable on currently available trichomonas nucleic acid amplification tests

    Show Resources
    You May Also Like
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources
    Attendees
    • See more